标题
Potential SARS-CoV-2 main protease inhibitors
作者
关键词
-
出版物
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2020-12-10
DOI
10.1016/j.drudis.2020.12.005
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
- (2020) Jared S. Morse et al. CHEMBIOCHEM
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
- (2020) Linlin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
- (2020) Jiabao Xu et al. Viruses-Basel
- Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
- (2020) Hossam M. Ashour et al. Pathogens
- Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
- (2020) Sen Liu et al. BIOINFORMATICS
- Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19
- (2020) Anas Shamsi et al. BIOSCIENCE REPORTS
- Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
- (2020) Aleix Gimeno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
- (2020) Sourav Das et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach
- (2020) Lovika Mittal et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors
- (2020) Vijay Kumar Bhardwaj et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
- (2020) Rakesh S. Joshi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
- (2020) Nisha Muralidharan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
- (2020) Junmei Wang Journal of Chemical Information and Modeling
- Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
- (2020) Davide Gentile et al. Marine Drugs
- Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
- (2020) Anh-Tien Ton et al. Molecular Informatics
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
- (2020) Jean-Jacques Mourad et al. Nature Reviews Cardiology
- Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals
- (2020) Ivan Seah et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
- (2020) Muhammad Usman Mirza et al. Journal of Pharmaceutical Analysis
- Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
- (2020) Muhammad Tahir ul Qamar et al. Journal of Pharmaceutical Analysis
- Identification of potential binders of the main protease 3CLpro of the COVID-19 via structure-based ligand design and molecular modeling
- (2020) Marina Macchiagodena et al. CHEMICAL PHYSICS LETTERS
- Leucoefdin a potential inhibitor against SARS CoV-2 Mpro
- (2020) Amit Singh et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro
- (2020) Mubarak A. Alamri et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
- (2020) Son Tung Ngo et al. Journal of Chemical Information and Modeling
- Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach
- (2020) Arun Bahadur Gurung et al. LIFE SCIENCES
- Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
- (2020) Mahmoud Kandeel et al. LIFE SCIENCES
- 3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials
- (2020) Mekonnen Sisay PHARMACOLOGICAL RESEARCH
- Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
- (2020) Pritam Kumar Panda et al. Science Advances
- Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
- (2020) Alicia Jiménez-Alberto et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor
- (2019) Wen Cui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design
- (2019) Miha Skalic et al. MOLECULAR PHARMACEUTICS
- Michael Acceptor-Based Peptidomimetic Inhibitor of Main Protease from Porcine Epidemic Diarrhea Virus
- (2017) Fenghua Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Jonathan Kil et al. LANCET
- Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
- (2017) Seth W. Dickey et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Covalent Ligands via Noncovalent Docking by Dissecting Covalent Docking Based on a “Steric-Clashes Alleviating Receptor (SCAR)” Strategy
- (2016) Yuanbao Ai et al. Journal of Chemical Information and Modeling
- Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing
- (2016) Charles Masaki et al. PSYCHOPHARMACOLOGY
- Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design
- (2016) Fenghua Wang et al. Scientific Reports
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors
- (2015) Fenghua Wang et al. JOURNAL OF VIROLOGY
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus FabI Enzyme–Product Complex
- (2013) Andrew Chang et al. BIOCHEMISTRY
- The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease
- (2013) Zhilin Ren et al. Protein & Cell
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
- Drug–target residence time: critical information for lead optimization
- (2010) Hao Lu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds
- (2009) Cheng-Chung Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of the Main Protease from a Global Infectious Human Coronavirus, HCoV-HKU1
- (2008) Q. Zhao et al. JOURNAL OF VIROLOGY
- Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
- (2007) Valerie Grum-Tokars et al. VIRUS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now